RISW2026
Back to all people

Yanyao Yi

Eli Lilly and Company
4 appearances in the program

Sessions & presentations

SC01: Biomedical AI Foundation Models and Applications in Drug Development
Short Course Half Day · Wed, Sep 16 , 8:30 AM
Co-Instructor
PS43: From FDA Draft Guidance to Practice: Credible and Fit-for-Purpose AI in Clinical Drug Development and Post-Market Surveillance
Parallel · Fri, Sep 18 , 1:30 PM
Co-Organizer
PS43: From FDA Draft Guidance to Practice: Credible and Fit-for-Purpose AI in Clinical Drug Development and Post-Market Surveillance
Parallel · Fri, Sep 18 , 1:30 PM
Chair
Poster Session I
Presentation: Evolving Longitudinal Patient Histories and Re-enrollment in Master Protocol Trials
Posters · Thu, Sep 17 , 5:45 PM
CoAuthor
↑